Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

SciClone Pharmaceuticals Inc (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

SciClone Pharmaceuticals Inc (SciClone) is a pharmaceutical company that develops and commercializes novel therapies for varied therapeutic areas such as oncology, cardiovascular disorders and infectious diseases. The companys lead product, Zadaxin (thymalfasin), an immunostimulatory agent is used for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), sepsis, cancer and as an immune system enhancer. SciClone also markets other pharmaceutical products in China including DC Bead, a product for the embolization of malignant hypervascularized tumors. Its pipeline products comprise potential therapeutic drugs such as cardiovascular drugs, Angiomax and Neucardin, antibiotic Vibativ and others. The company has presence in Beijing and Shanghai in China; Hong Kong and Vietnam. SciClone is headquartered in Foster City, California, the US.

SciClone Pharmaceuticals Inc (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

TABLE OF CONTENTS

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Soligenix Enters Into Co-Marketing Agreement With SciClone Pharma For SGX942 10
Sanofi-Aventis Expands Co-Promotion Agreement with NovaMed Pharma 11
Licensing Agreements 11
SciClone Pharma Enters into Licensing Agreement with Soligenix 11
SciClone Pharma Enters into Licensing Agreement with Ability Pharma 12
Theravance Biopharma Enters into Co-Development Agreement with SciClone Pharma 13
Medicines Company Enters into Licensing Agreement with SciClone 14
SciClone Pharma Enters Into Licensing Agreement With Taiwan Liposome For ProFlow 15
SciClone Pharma And Zensun (Shanghai) Science & Technology Enter Into Licensing Agreement For Neucardin 17
Equity Offering 18
SciClone Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 18
Acquisition 19
GL Capital and ABG Management Plans to Acquire SciClone Pharma for up to USD570 Million 19
SciClone Pharma Acquires NovaMed Pharma 20
SciClone Pharmaceuticals Inc - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 10, 2017: SciClone Reports First Quarter 2017 Financial Results 26
Mar 06, 2017: SciClone Reports 2016 Financial Results And 2017 Outlook 28
Nov 09, 2016: SciClone Reports Third Quarter 2016 Financial Results 30
Aug 09, 2016: SciClone Reports Second Quarter 2016 Financial Results 32
May 10, 2016: SciClone Reports First Quarter 2016 Financial Results 34
Mar 10, 2016: SciClone Reports 2015 Financial Results 35
Jan 11, 2016: SciClone Announces Preliminary 2015 Revenue 37
Other Significant Developments 38
Jul 19, 2016: SciClone Provides Update On Strategic Review Process 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
SciClone Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Soligenix Enters Into Co-Marketing Agreement With SciClone Pharma For SGX942 10
Sanofi-Aventis Expands Co-Promotion Agreement with NovaMed Pharma 11
SciClone Pharma Enters into Licensing Agreement with Soligenix 11
SciClone Pharma Enters into Licensing Agreement with Ability Pharma 12
Theravance Biopharma Enters into Co-Development Agreement with SciClone Pharma 13
Medicines Company Enters into Licensing Agreement with SciClone 14
SciClone Pharma Enters Into Licensing Agreement With Taiwan Liposome For ProFlow 15
SciClone Pharma And Zensun (Shanghai) Science & Technology Enter Into Licensing Agreement For Neucardin 17
SciClone Pharma Files Registration Statement For Public Offering Of Securities For US$100 Million 18
GL Capital and ABG Management Plans to Acquire SciClone Pharma for up to USD570 Million 19
SciClone Pharma Acquires NovaMed Pharma 20
SciClone Pharmaceuticals Inc, Key Competitors 23
SciClone Pharmaceuticals Inc, Key Employees 24
SciClone Pharmaceuticals Inc, Subsidiaries 25

List Of Figures

Burmeister & Wain Scandinavian Contractor A/S, Power, Deals By Year, 2011 to YTD 2017 22
Burmeister & Wain Scandinavian Contractor A/S, Power, Deals by Type, 2011 to YTD 2017 23

RELATED REPORTS

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Rocket Pharmaceuticals Inc (Rocket Pharma), formerly Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company. It focuses on the discovery and development of novel therapeutics for the treatment of glaucoma and

USD 300 View Report

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

SciClone Pharmaceuticals Inc (SCLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Rocket Pharmaceuticals Inc (RCKT) - Financial and Strategic SWOT Analysis Review

Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review

FAQs